Regenerative biotechnology
Gencell® CTM Metformina
Mesenchymal stem cells pretreated with metformin for metabolic and regenerative support.
Therapy of mesenchymal stem cells pretreated with metformin, aimed at modulating inflammation, improving glycemic regulation, and promoting tissue regeneration in metabolic and musculoskeletal conditions.
Composition
Mesenchymal stem cells pretreated with metformin.
Pharmaceutical form
Injectable solution.
Presentation
Monovette with 4 ml.
Therapeutic Properties
They promote tissue repair through immunomodulation, inhibition of apoptosis, stimulation of cellular proliferation, promotion of angiogenesis, and improved glucose uptake by reducing insulin resistance.
- Modulation of tissue inflammation.
- Improvement of glucose uptake.
- Reduction of insulin resistance.
- Inhibition of cellular apoptosis.
- Stimulation of tissue regeneration.
- Promotion of angiogenesis.
- Support for glycemic regulation.
- Promotes bone and cartilage regeneration.
Mechanism of action & Clinical data
They migrate to injured tissues, modulate inflammation, inhibit apoptosis and, via OCT-1, increase GLUT2 and GLUT4 expression, improving glycemic homeostasis and tissue regeneration.